U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 785 records

Showing results for "prescribing".

  1. Attention Deficit Hyperactivity Disorder: Executive Summary (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/adhd_executive.pdf
    October 01, 2011 - National trends in the prevalence of attention­ deficit/hyperactivity disorder and the prescribing of

  2. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - Victoza (liraglutide (RDNA origin) injection) injection, solution prescribing information.

  3. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Lucentis (ranibizumab injection) highlights of prescribing information. [internet].

  4. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Lucentis (ranibizumab injection) highlights of prescribing information. [internet].

  5. Disposition of Comments for CER 195 Management of Uterine Fibroids (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
    December 14, 2017 - only physicians with a prescriber’s agreement with the manufacturer (Danco) can obtain the drug and prescribing

  6. Osteoporosis-Bone-Fracture Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
    March 01, 2012 - Know About Whom To Treat and How For clinicians, this report contributes information that may inform prescribing

  7. Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
    February 01, 2012 - particularly SGAs, for children and adolescents has increased markedly during the past 20 years.5-9 Prescribing … In general, much prescribing of SGAs for children and adolescents does not appear to be guided by evidence … Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000;238(8):1025-30. … Studies shed light on risks and trends in pediatric antipsychotic prescribing.

  8. Disposition of Comments for Technical Brief 20 Core Functionality in Pediatric Electronic Health Records (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pediatric-ehr_disposition-comments.pdf
    May 01, 2015 - We agree that medication prescribing has some areas that can be improved (e.g. indication-based dosing … We refer to CDS extensively during the brief, often entirely separate from medication prescribing. … Medication management and electronic prescribing have many pediatric requirements that are addressed

  9. Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorder | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/research-protocol
    July 01, 2014 - Hospital Ambulatory Medical Care Survey, Cooper and colleagues 28 demonstrated that antipsychotic prescribing … Furthermore, the medication prescribing increases were greater for non-approved indications including … Trends in prescribing of antipsychotic medications for US children. Ambul Pediatr. 2006;6:79-83.

  10. Disposition of Comments: Management of Colonic Diverticulitis (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diverticulitis-comments.pdf
    October 12, 2020 - Disposition of Comments: Management of Colonic Diverticulitis Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Management of Colonic Diverticulitis Draft report available for public comment from June 2, 2020 to June 29, 2020. Research Review Citation: Balk EM,…

  11. Executive Summary - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-executive-summary-2023-update.pdf
    January 01, 2023 - Executive Summary - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update Comparative Effectiveness Review Number 250 Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update Executive Summary Main Points …

  12. Noninvasive, Nonpharmacological Treatment for Chronic Pain (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharma-treatment-pain_research-protocol-amended.pdf
    September 20, 2017 - The 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain recommend that non-opioid therapy … CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

  13. Infectious Disease Including HIV/AIDS #09 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
    December 01, 2013 - Infectious Disease Including HIV/AIDS #09 AHRQ Healthcare Horizon Scanning System – Potential High Impact Interventions Report Priority Area 09: Infectious Disease including HIV/AIDS Potential High Impact Interventions Prepared for: Agency for Healthcare Research and Quality U.S. Department of H…

  14. Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents - Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
    November 01, 2021 - Age- and Sex-Specific Increases in Stimulant Prescribing Rates—California, 2008-2017.

  15. Transparency of Reporting Requirements: Tympanostomy Tubes | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/transparency-tympanostomy/research-protocol
    September 03, 2016 - Transparency of Reporting Requirements: Tympanostomy Tubes Research Protocol September 3, 2016 Download Main Document PDF 295.4 KB Background Information biases, including publication bias, time-lag bias, selective outcome reporting bias, selective analysis bias, and fraud are major threats to the val…

  16. Slide 1 (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/module_i1.ppt
    October 31, 2011 - Slide 1 Engaging Stakeholders in the Effective Health Care Program Information and tools for researchers and investigators Numeric

  17. Transparency of Reporting Requirements: Tympanostomy Tubes (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research-protocol.pdf
    September 02, 2016 - Transparency of Reporting Requirements: Tympanostomy Tubes Source: www.effectivehealthcare.ahrq.gov Published online: September 2, 2016 Evidence-based Practice Center Methodology Repor t Protocol Project Title: Transparency of Repor ting Requirements Repor t Topic: Tympanostomy Tubes I. Background Info…

  18. 15 Crosscutting Potential High Impact 2012-12-11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Crosscutting Interventions and Programs Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. HHS…

  19. Appendixes A-H: Telehealth for Women (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/telehealth-women-appendixes-a-h.pdf
    January 01, 2021 - Expanding adolescent access to hormonal contraception: an update on over-the-counter, pharmacist prescribing … Breaking down barriers to birth control access: an assessment of online platforms prescribing birth

  20. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
    January 01, 2023 - heterogeneous and subtle than those in children and adolescents. 5 For the period 1999 to 2003, national prescribing … indication is ADHD and the rise in the frequency of this diagnosis is the primary cause of increased prescribing
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites